NASDAQ:CNTX

Context Therapeutics Stock Forecast

etoro logo Buy CNTX
*Your capital is at risk
$0.615
-0.0157 (-2.49%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of CNTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Context Therapeutics Inc. stock price ended at $0.615 on Thursday, after losing 2.49%
(Updated on Jul 16, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 02, 2026 Loss -74.60%

The Context Therapeutics Inc. stock price fell by -2.49% on the last day (Thursday, 16th Jul 2026) from $0.630 to $0.615. During the last trading day the stock fluctuated 6.27% from a day low at $0.600 to a day high of $0.638. The price has fallen in 6 of the last 10 days but is still up by 1.04% over the past 2 weeks. Volume has increased on the last day by 151 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $836.32 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -60.37% during the next 3 months and, with a 90% probability hold a price between $0.0440 and $0.639 at the end of this 3-month period.

CNTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has risen 10.96%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Context Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.619 and $1.17. A break-up above any of these levels will issue buy signals. Context Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Context Therapeutics Inc. stock

Context Therapeutics Inc. finds support from accumulated volume at $0.600 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0376 between high and low, or 6.27%. For the last week, the stock has had daily average volatility of 8.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTX) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Context Therapeutics Inc. to open at $0.617, and during the day (based on 14 day Average True Range), to move between $0.565 and $0.664, which gives a possible trading interval of +/-$0.0992 (+/-17.57%) up or down from last closing price. If Context Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 17.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.600 (2.38%) than the resistance at $0.630 (2.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Context Therapeutics Inc. stock A Buy?

Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.385 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $0.617 ( 0.456%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTX Performance

Trading levels for CNTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.655 6.57%
R2 0.641 4.24%
R1 0.632 2.79%
Price 0.615
S1 0.603 -1.88%
S2 0.594 -3.33%
S3 0.580 -5.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.679 10.49%
R2 0.650 5.81%
R1 0.630 2.49%
Price 0.615
S1 0.600 -2.38%
S2 0.595 -3.27%
S3 0.580 -5.63%

FAQ

What is the symbol for Context Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Context Therapeutics Inc. is CNTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Context Therapeutics Inc. Stock?
Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Context Therapeutics Inc. Stock?
Context Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Context Therapeutics Inc. Stock.

What's the current price of Context Therapeutics Inc. Stock?
As of the end of day on the Jul 16, 2026, the price of an Context Therapeutics Inc. (CNTX) share was $0.615.

What is the 52-week high and low for Context Therapeutics Inc. Stock?
The 52-week high for Context Therapeutics Inc. Stock is $3.62 and the 52-week low is $0.545.

What is the market capitalization of Context Therapeutics Inc. Stock?
As of the Jul 16, 2026, the market capitalization of Context Therapeutics Inc. is 56.469M.

When is the next earnings date for Context Therapeutics Inc.?
The upcoming earnings date for Context Therapeutics Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT CONTEXT THERAPEUTICS INC.
Context Therapeutics
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE